Ethypharm
Script error: No such module "Draft topics".
Script error: No such module "AfC topic".
Ethypharm is a specialty pharmaceutical company with European roots founded in 1977.:[1] and headquartered in Saint-Cloud, France. With a turnover of €357 million in 2020 [2] and more than 1,400 employees worldwide, Ethypharm focuses primarily on two areas: the Central Nervous System (CNS) and Hospital Injectables.
| ISIN | 🆔 |
|---|---|
| Industry | Pharmaceutical Industry |
| Founded 📆 | 1977 in Saint-Cloud, France |
| Founder 👔 | |
| Headquarters 🏙️ | Saint-Cloud, France |
Area served 🗺️ | |
| Products 📟 | Medication, Central Nervous System and Hospital Injectables |
| Revenue🤑 | 357 Mil euro [2] |
| Members | |
Number of employees | 1400[3] |
| 🌐 Website | ethypharm.com |
| 📇 Address | |
| 📞 telephone | |
History[edit]
1977 - 2000[edit]
Ethypharm was founded in 1977 [4] opening its first factory in Houdan, France. Ethypharm promptly began to focus on drug delivery and modified release dosage forms, to provide new solutions to facilitate the intake of active pharmaceutical ingredients.
Up until the 2000s, Ethypharm depended exclusively on external partners for the commercialisation of its products. By relying on partnerships, Ethypharm developed its network of associates, thereby enabling it to expand the availability of its products both in Europe and internationally, notably in North America and China [5] (from 1995).
2000s[edit]
At the beginning of the 21st century, many countries passed regulations to encourage the use of generic medicines[6], opening new opportunities for the pharmaceutical industry. Ethypharm developed generic medicines that presented formulation and bioequivalence challenges, such as omeprazole, buprenorphine, fenofibrate and esomeprazole.
From 2010, Ethypharm also started to specialise in specific therapeutic areas where the company already had products in its portfolio: pain stemming from its morphine[7] range and controlled medicine know-how, and addiction based on its buprenorphine range and pipeline product, baclofen[8] for alcohol dependence.
Since 2010[edit]
In 2013, Ethypharm undertook a strategic shift and began selling directly in France through the acquisition of Dexo[9]. The acquisition of DB Ashbourne [10] in 2015 allowed Ethypharm to set a direct foot in the United Kingdom.
In 2015, Ethypharm also registered a new subsidiary in Germany[11], Ethypharm GMBH.
in January 2017 Ethypharm announced the acquisition of Martindale Pharma [12], a UK-based specialty pharmaceutical company specialising in opioid dependence, critical care and injectables.
In April 2021 Ethypharm announced the opening of its Italian subsidiary, a few months before announcing the acquisition of Altan, a Spanish pharmaceutical company, thus entering the Spanish market and establishing a direct commercial presence in the top 5 European markets.
In April 2021, Ethypharm opened a new entity: Ethypharm Digital Therapy[13], following its agreement with GAIA AG for the commercialisation of deprexis©[14].
Manufacturing sites[edit]
In December 2021, Ethypharm operated 6 manufacturing sites [15]
In France:
- In Le Grand-Quevilly (Normandy)[16]
- In Châteauneuf-en-Thymerais[17]
In the United Kingdom:
- In Romford (Greater London).
In Spain:
- In Bernedo (Basque country)
- In Casarrubios del Monte (Castile-La Mancha)
In China:
- In Qingpu district of Shanghai
Products[edit]
Ethypharm is specialised in two areas, the Central Nervous System and Hospital Injectables.
In December 2021, Ethypharm received approval for the first Immediate Release orodispersible tablets of morphine in Germany, France and the United Kingdom[18]
In 2021 Ethypharm was selected to participate in the medical cannabis trials in France[19] which started in March 2021. Ethypharm also entered into a partnership with the company Clever Leaves to market medical cannabis in Germany[20]
References[edit]
- ↑ "Booster l'innovation et sauvegarder des emplois". L'Europe s'engage en France, le portail des Fonds européens. September 27, 2017.
- ↑ 2.0 2.1 "Bertrand Deluard (Ethypharm) : "Nous structurons une business unit Ethypharm Digital Therapeutics" - mind Health". www.mindhealth.fr.
- ↑ "Ethypharm signe l'acquisition de Pharmy II". April 22, 2019.
- ↑ "Cinq candidats sur les rangs pour acheter le laboratoire français Ethypharm". Les Echos. January 8, 2007.
- ↑ Nouvelle, L'Usine (June 5, 2006). "Drug delivery : Ethypharm prend son envol en Asie" – via www.usinenouvelle.com.
- ↑ "Campagne sur les médicaments génériques - Sénat". www.senat.fr.
- ↑ Nouvelle, L'Usine (October 18, 2004). "Produits et marchés : Morphine : AMM pour Ethypharm au Danemark" – via www.usinenouvelle.com.
- ↑ "» L'AP-HP et Ethypharm signent un accord relatif au baclofène MyPharma Editions | L'Info Industrie & Politique de Santé".
- ↑ "Ethypharm absorbe le laboratoire Dexo". Capital Finance. December 5, 2013.
- ↑ "DB Ashbourne Limited has been acquired by Ethypharm S.A | Deals | Oaklins Norway: Mid-market M&A and financial advice globally".
- ↑ "ETHYPHARM GmbH, Schönefeld, Germany". www.northdata.com.
- ↑ "Ethypharm acquiert le britannique Martindale Pharma". Capital Finance. January 20, 2017.
- ↑ "ETHYPHARM DIGITAL THERAPY (SAINT-CLOUD) Chiffre d'affaires, résultat, bilans sur SOCIETE.COM - 879453298". www.societe.com.
- ↑ "Ethypharm lance la première thérapie numérique dans la dépression sans attendre son éventuel remboursement". www.ticpharma.com.
- ↑ "International footprint - Ethypharm".
- ↑ Nouvelle, L'Usine (February 20, 2013). "Ethypharm investit 8 millions d'euros dans ses usines" – via www.usinenouvelle.com.
- ↑ France, Centre (May 8, 2020). "Croissance - Le laboratoire Ethypharm, à Châteauneuf-en-Thymerais, augmente sa production du Paracétamol et du Propanolol". www.lechorepublicain.fr.
- ↑ https://www.lequotidiendupharmacien.fr/medicament-parapharmacie/medicament/actiskenan-nouvelle-formule-bientot-en-pharmacie
- ↑ "Cannabis thérapeutique : la France "à la traîne", les laboratoires à la manoeuvre". Franceinfo. February 17, 2021.
- ↑ Hasse, Javier. "Pharmaceutical Company Ethypharm Partners With Clever Leaves To Sell Cannabis In Germany". Benzinga.
This article "Ethypharm" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Ethypharm. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
